AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |
Back to Blog
Flame hemorrhage vs dot blot hemorrhages1/11/2024 ![]() Papers of particular interest, published recently, have been highlighted as: įong DS, Aiello LP, Ferris FL, Klein R. Further research is needed to determine the ideal method of delivery and timing of the treatment. Over the last decade, anti-VEGF has become an increasingly common treatment modality for the management of proliferative diabetic retinopathy, vitreous hemorrhages, and tractional retinal detachments. Future research into sustained delivery and release of anti-VEGF, reducing the need for frequent in-office injections, may prove to be additionally beneficial. Modern surgical techniques and instrumentation have also allowed for improved patient outcomes. Recent FindingsĪdvances in earlier treatment of proliferative diabetic retinopathy, especially with anti-VEGF injections, allow for a reduction in severity, improved vision, and more controlled and successful surgery. New advances, including anti-vascular endothelial growth factor (VEGF) medications and innovative microsurgical instruments, have provided additional methods for the management of diabetic retinopathy in the clinic and in the operating room, leading to improved outcomes. The proliferation of new blood vessels, vitreous hemorrhage, and tractional retinal detachments may ultimately result and can be devastating to visual function. ![]() As the duration of diabetes and blood glucose levels increase, these changes become more severe. Diabetes can be associated with profound visual loss due to several mechanisms.
0 Comments
Read More
Leave a Reply. |